Skip to main content
SpringerLink
Log in

Aerosolised antibiotics in critical care

  • What's New in Intensive Care
  • Published:
Intensive Care Medicine Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Data availability

Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.

References

  1. Sun Q, Chang W, Liu X et al (2022) Aerosol therapy during mechanical ventilation in intensive care units: a questionnaire-based survey of 2203 ICU medical staff in China. J Intensive Med 2:189–194

    Article  PubMed  PubMed Central  Google Scholar 

  2. Li J, Williams L, Fink JB (2022) The impact of high-flow nasal cannula device, nebulizer type, and placement on trans-nasal aerosol drug delivery: an in vitro study. Respir Care 67:1–8

    Article  PubMed  Google Scholar 

  3. Dugernier J, Hesse M, Jumetz T et al (2017) Aerosol delivery with two nebulizers through high-flow nasal cannula: a randomized cross-over single-photon emission computed tomography-computed tomography study. J Aerosol Med Pulm Drug Del 30:349–358

    Article  CAS  Google Scholar 

  4. Rello J, Rouby JJ, Sole-Lleonart C et al (2017) Key considerations on nebulization of antimicrobial agents to mechanically ventilated patients. Clin Microbiol Infect 23:640–646

    Article  CAS  PubMed  Google Scholar 

  5. Rouby JJ, Sole-Lleonart RJ, the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (2020) Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin. Intensive Care Med 2020(46):766–770

    Article  Google Scholar 

  6. Boisson M, Bouglé A, Sole-Lleonart C et al (2022) Nebulized antibiotics for healthcare- and ventilator-associated pneumonia. Semin Respir Crit Care Med 43:255–270

    Article  PubMed  Google Scholar 

  7. Rouby JJ, Monsel A, Ehrmann S, Bouglé A, Laterre PF (2020) The INHALE trial: multiple reasons for a negative result. Lancet Inf Dis 20(7):778–779

    Article  Google Scholar 

  8. Tejada S, Ramírez-Estrada S, Forero CG et al (2022) Safety and efficacy of devices delivering inhaled antibiotics among adults with non-cystic fibrosis bronchiectasis: a systematic review and a network meta-analysis. Antibiotics (Basel) 11(2):275

    Article  CAS  PubMed  Google Scholar 

  9. Langton Hewer SC, Smyth AR (2017) Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. Cochrane Database Syst Rev 4:CD004197

    PubMed  Google Scholar 

  10. Alves J, Alp E, Koulenti D et al SANEME-2 Investigators (2018) Nebulization of antimicrobial agents in mechanically ventilated adults in 2017: an international cross-sectional survey. Eur J Clin Microbiol Infect Dis 37:785–94

  11. Solé-Lleonart C, Rouby JJ, Blot S et al (2017) Nebulization of anti-infective agents in invasively mechanically ventilated adults: a systematic review and meta-analysis. Anesthesiology 126:890–908

    Article  PubMed  Google Scholar 

  12. Rello J, Solé-Lleonart C, Rouby JJ et al (2017) Use of nebulized antimicrobials for the treatment of respiratory infections in invasively mechanically ventilated adults: a position paper from the European Society of Clinical Microbiology and Infectious Diseases. Clin Microbiol Infect 23:629–639

    Article  CAS  PubMed  Google Scholar 

  13. Kollef MH, Ricard JD, Roux DZ et al (2017) A randomized trial of the amikacin fosfomycin inhalation system for the adjunctive therapy of gram-negative ventilator-associated pneumonia: IASIS trial. Chest 151:1239–1246

    Article  PubMed  Google Scholar 

  14. Niederman MS, Alder J, Bassetti M et al (2020) Inhaled amikacin adjunctive to intravenous standard-of-care antibiotics in mechanically ventilated patients with Gram-negative pneumonia (INHALE): a doubleblind, randomised, placebo-controlled, phase 3, superiority trial. Lancet Infect Dis 20:330–340

    Article  CAS  PubMed  Google Scholar 

  15. Stokker J, Karami M, Hoek R, Gommers D, van der Eerden M (2020) Effect of adjunctive tobramycin inhalation versus placebo on early clinical response in the treatment of ventilator-associated pneumonia: the VAPORISE randomized-controlled trial. Intensive Care Med 46:546–548

    Article  PubMed  PubMed Central  Google Scholar 

  16. Rouby JJ, Monsel A, Leone M, Mimoz O, Laterre P-F, Pugin J (2020) The IASIS, INHALE and VAPORISE trials. Reasons for a triple failure: Study design, aminoglycosides dosing and technique of nebulisation. Anaesth Crit Care Pain Med 39:179–183

    Article  PubMed  Google Scholar 

  17. Monsel A, Torres A, Zhu Y, Pugin J, Rello J, Rouby JJ, on behalf of the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (ENAVAP) (2021) Nebulized antibiotics for ventilator-associated pneumonia: methodological framework for future multicenter randomized controlled trials. Curr Opin Infect Dis 34:156–168

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The following members of the European Investigators Network for Nebulized Antibiotics in Ventilator-associated Pneumonia (ENAVAP) endorsed the final manuscript: Kostoula Arvaniti arvanitik@hotmail.com, Papageorgiou Hospital of Thessaloniki, Intensive Care Unit Department, Thessaloniki, Greece; Mona Assefi mona.assefi@aphp.fr Medicine Sorbonne University, Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Matteo Bassetti matteo.bassetti@asuiud.sanita.fvg.it, Infectious Diseases Clinic, Department of Health Sciences, University of Genoa, Genoa and Hospital Policlinico San Martino – IRCCS, Genoa, Italy; Stijn Blot stijn.blot@UGent.be, Department of Internal Medicine and Pediatrics, Ghent University, Ghent, Belgium; Matthieu Boisson matthieu.boisson@chu-poitiers.fr, University of Poitiers, Anaesthesiology and Intensive Care Department, University hospital of Poitiers, Poitiers, France; Jean-Michel Constantin jean-michel.constantin@aphp.fr, Medicine Sorbonne University, Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Jayesh Dhanani jadhanani@hotmail.com, Burns Trauma and Critical Care Research Centre and Centre for Translational Anti-infective Pharmacodynamics, The University of Queensland, Butterfield Street, Herston, Brisbane, Australia; George Dimopoulos gdimop@med.uoa.gr, Department of Critical Care Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, Athens, Greece; Jonathan Dugernier jonathan.dugernier@rhne.ch, Department of Physiotherapy, Neuchâtel hospital, Neuchâtel, Switzerland; Pauline Dureau pauline.dureau@aphp.fr Medicine Sorbonne University, Anaesthesiology and Critical Care, Cardiology Institute, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Timothy Felton timothy.felton@manchester.ac.uk, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, United Kingdom; Antonia Koutsoukou koutsoukou@yahoo.gr, Intensive Care Unit, First Department of Respiratory Medicine, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Anna Kyriakoudi Annkyr@gmail.com, Intensive Care Unit, First Department of Respiratory Medicine, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Pierre-François Laterre pierre-francois.laterre@uclouvain.be, St. Luc Clinical Coordinating Center, Department of Critical Care Medicine, St Luc University Hospital, Université Catholique de Louvain, Brussels, Belgium; Marc Leone marc.leone@ap-hm.fr, University Aix-Marseille, Department of Anaesthesiology and Critical Care, North Hospital, Marseille, France; Victoria Lepère, victoria.lepere@aphp.fr, Medicine Sorbonne University, Anaesthesiology and Critical Care, Cardiology Institute, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France; Gianluigi Li Bassi g.libassi@uq.edu.au Critical Care Research Group, The Prince Charles Hospital, Brisbane, University of Queensland, Faculty of Medicine, Brisbane, Australia, and Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain; Xuelian Liao xuelianliao@hotmail.com, Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, China; Olivier Mimoz o.mimoz@chu-poitiers.fr, University of Poitiers, Anaesthesiology and Intensive Care Department, University hospital of Poitiers, Poitiers, France; Antoine Monsel antoine.monsel@aphp.fr, (1) Medicine Sorbonne University, Multidisciplinary Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France (2) Institut National de la Santé et de la Recherche Médicale (INSERM), Unité mixte de recherche (UMR)-S 959, Immunology-Immunopathology-Immunotherapy (I3), Paris, France (AM), and Biotherapy (CIC-BTi) and Inflammation-Immunopathology-Biotherapy Department (DHU i2B), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France; Girish B Nair Girish.Nair@beaumont.org Interstitial Lung Disease Program Director Pulmonary Research OUWB School of Medicine, Royal Oak, MI, USA ; Michael Niederman msn9004@med.cornell Pulmonary and Critical Care, New York Presbyterian/ Weill Cornell Medical Center, Weill Cornell Medical College, New York, USA; Lucy B Palmer lucy.b.palmer@stonybrook.edu Stony Brook University Medical Center Pulmonary, Critical Care and Sleep Division, SUNY at Stony Brook, HSC T17-040, Stony Brook, New York, USA; Paolo Pelosi ppelosi@hotmail.com Anaesthesiology and Critical Care, San Martino Policlinico Hospital, IRCCS for Oncology and Neurosciences, Genoa, Italy. Department of Surgical Sciences and Integrated Diagnostics, University of Genoa, Genoa, Italy; Jose Manuel Pereira jmcrpereira@yahoo.com, Emergency and Intensive Care Department, Centro Hospitalar São João EPE, Faculdade de Medicina da Universidade do Porto, Porto, Portugal; Konstantinos Pontikis kostis_pontikis@yahoo.gr, Intensive Care Unit, First Department of Respiratory Medicine, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Garyphalia Poulakou gpoulakou@gmail.com, Third Department of Medicine, School of Medicine, Sotiria General Hospital, National and Kapodistrian University of Athens, Athens, Greece; Jérôme Pugin jerome.pugin@unige.ch, Intensive Care Division, University Hospitals of Geneva, Geneva, Switzerland; Chuanyun Qian, qianchuanyun@126.com, Emergency department, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China; Jie-ming Qu jmqu0906@163.com, Department of Pulmonary and Critical Care Medicine, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine, Shanghai, China; Institute of Respiratory Disease, Shanghai Jiao-tong University School of Medicine, Shanghai, China; Jason Roberts j.roberts2@uq.edu.au, (1) University of Queensland Centre for Clinical Research, Faculty of Medicine & Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Brisbane, Australia (2) Departments of Pharmacy and Intensive Care Medicine, Royal Brisbane and Women’s Hospital, Brisbane, Australia (3) Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes France; Christina Routsi chroutsi@hotmail.com, First Department of Intensive Care, School of Medicine, Evangelismos Hospital, National and Kapodistrian University of Athens, Athens, Greece; Melda Türkoğlu meldaturkoglu@yahoo.com.tr, Subdivision of Critical Care, Internal Medicine Intensive Care Unit, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey; Tobias Welte welte.tobias@mh-hannover.de, University of Hannover, School of Medicine, Hannover, Germany; Michel Wolff m.wolff@ghu-paris.fr , Service de Neuro-Réanimation, Groupe Hospitalo-Universitaire Paris Psychiatrie & Neurosciences, Hôpital Ste Anne Paris France; Jing Xia xiajing@kmmu.edu.cn, Emergency department, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China; Li Yang, 1197815424@qq.com, Emergency department, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China; Ting Yang, 459803440@qq.com, Emergency department, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China; Ying-gang Zhu robinzyg@gmail.com, Department of Pulmonary and Critical Care Medicine, Hua-dong Hospital, Fudan University, Shanghai, China.

Funding

No funding supported this manuscript.

Author information

Authors and Affiliations

  1. Global Health eCore, Vall d’Hebron Institute of Research (VHIR), Ps. Vall d’Hebron 129. AMI-14, 08035, Barcelona, Spain

    Jordi Rello

  2. Centro de Investigacion Biomedica en Red de Enfermedades Respiratorias (CIBERES), Instituto de Salud Carlos III, Madrid, Spain

    Jordi Rello

  3. Unité de Recherche FOVERA, Réanimation Douleur Urgences, Centre Hospitalier Universitaire de Nîmes, Nîmes, France

    Jordi Rello

  4. Cardiovascular Intensive Care Unit, Department of Anaesthesiology and Critical Care, La Pitié-Salpêtrière Hospital, Assistance Publique Hôpitaux de Paris, Paris, France

    Adrien Bouglé

  5. Research Department, Departement Médico-Universitaire DREAM (DMU DREAM), Sorbonne University of Paris, Paris, France

    Jean-Jacques Rouby

Authors
  1. Jordi Rello
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Adrien Bouglé
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jean-Jacques Rouby
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

JJR and JR wrote the first draft of the manuscript. JJR conceived and drafted the figure. AB contributed towards the critical revision of the manuscript for important intellectual content and confirm the integrity of the work.

Corresponding author

Correspondence to Jordi Rello.

Ethics declarations

Conflicts of interest

JR served in advisory boards for BAYER, Pfizer, Merck and served in the speaker’s bureau for Norma-Hellas. AB and JJR declare no conflict of interest.

Ethical approval

An approval by an ethics committee was not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rello, J., Bouglé, A. & Rouby, JJ. Aerosolised antibiotics in critical care. Intensive Care Med 49, 848–852 (2023). https://doi.org/10.1007/s00134-023-07036-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00134-023-07036-5

Search

Navigation